Evidence that mesoaccumbens dopamine and locomotor responses to nicotine in the rat are influenced by pretreatment dose and strain

被引:51
作者
Iyaniwura, TT
Wright, AE
Balfour, DJK [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Biomed Res, Dundee DD1 9SY, Scotland
[2] Inveresk Res Int Ltd, Tranent EH33 2NE, Scotland
[3] Univ Dundee, Ninewells Hosp & Med Sch, Dept Psychiat, Dundee DD1 9SY, Scotland
基金
英国惠康基金;
关键词
nicotine; mesoaccumbens dopamine; sensitisation; locomotor activity; rat; Sprague-Dawley; Lister hooded;
D O I
10.1007/s002130100852
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Sensitisation of the mesoaccumbens dopamine response to nicotine has been implicated in the development of nicotine dependence. This study explored the doses of nicotine that elicit the response in two strains of rats that differ in their baseline levels of activity. Methods: Male Sprague-Dawley and Lister hooded rats were pretreated with daily subcutaneous injections of (-)-nicotine for 7 days at doses ranging from 0.03 mg/kg to 0.90 mg/kg. Microdialysis studies were performed on day 9 in conscious freely moving rats, placed in an activity box and challenged with 0.4 mg/kg nicotine. Results: The acute administration of nicotine to drug-naive rats stimulated dopamine overflow in the accumbal shell but not the core. Sprague-Dawley rats, pretreated with nicotine (0.03 mg/kg/day and 0.10 mg/kg/day) showed increased basal overflow of dopamine in the accumbal core. Pretreatment with 0.10 mg/kg/day or 0.30 mg/kg/day, but not 0.03 mg/kg/day or 0.90 mg/kg/day, also caused sensitisation of the response to a nicotine challenge on the test day. Sensitisation of the locomotor response to nicotine exhibited a simple dose-response relationship, with the largest sensitisation being observed in animals pretreated with 0.90 mg/kg/day. In Lister hooded rats. pretreatment with nicotine reduced basal dopamine overflow in the accumbal core and did not cause sensitisation to a subsequent challenge with nicotine. Conclusions: Sensitisation of the mesoaccumbens dopamine response to nicotine is influenced by pretreatment dose and the strain of rats used. It is not related directly to the expression of sensitised locomotor responses to the drug and, therefore, may be implicated in other psychopharmacological properties of the drug, including dependence.
引用
收藏
页码:73 / 79
页数:7
相关论文
共 27 条
[1]   Sensitization of the mesoaccumbens dopamine response to nicotine [J].
Balfour, DJK ;
Benwell, MEM ;
Birrell, CE ;
Kelly, RJ ;
Al-Aloul, M .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (04) :1021-1030
[2]   The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence [J].
Balfour, DJK ;
Wright, AE ;
Benwell, MEM ;
Birrell, CE .
BEHAVIOURAL BRAIN RESEARCH, 2000, 113 (1-2) :73-83
[3]   Effects of acute D-CPPene on mesoaccumbens dopamine responses to nicotine in the rat [J].
Balfour, DJK ;
Birrell, CE ;
Moran, RJ ;
Benwell, MEM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 316 (2-3) :153-156
[4]   THE EFFECTS OF ACUTE AND REPEATED NICOTINE TREATMENT ON NUCLEUS-ACCUMBENS DOPAMINE AND LOCOMOTOR-ACTIVITY [J].
BENWELL, MEM ;
BALFOUR, DJK .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :849-856
[5]   Regional variation in the effects of nicotine on catecholamine overflow in rat brain [J].
Benwell, MEM ;
Balfour, DJK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (01) :13-20
[6]   The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine [J].
Birrell, CE ;
Balfour, DJK .
PSYCHOPHARMACOLOGY, 1998, 140 (02) :142-149
[7]   Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine [J].
Cadoni, C ;
Di Chiara, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (03) :R23-R25
[8]   Psychostimulant sensitization: differential changes in accumbal shell and core dopamine [J].
Cadoni, C ;
Solinas, M ;
Di Chiara, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 388 (01) :69-76
[9]   DOPAMINERGIC MECHANISMS IN THE LOCOMOTOR STIMULANT EFFECTS OF NICOTINE [J].
CLARKE, PBS .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1427-1432
[10]  
CLARKE PBS, 1988, J PHARMACOL EXP THER, V246, P701